Anderson et al., “A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function,” Nature 390:175-179; 1997. |
Baker, Stacey J. and Reddy, E. Premkumar, “Transducers of life and death: TNF receptor superfamily and associated proteins,” Oncogene, 12(1):1-9, 1996. |
Embl database entry HS421358; accession No. W74421, homo sapiens cDNA clone 346544 containing alu repetitive element, Hillier et al., June, 1996. |
Embl-est database accession No. R93478, yq16f06.rl homo sapian cDNA clone 197123 5′ sequence, Hillier et al., Aug. 1995. |
GenEmbl database accession No. X15271, locus.HSTRGV3F, human T-cell receptor gammaV3F, Lefranc, M. P., Mar., 1991. |
George et al., Current methods in sequence comparison and analysis, selected methods and applications, eds. David H. Schlesinger, Alan R. Liss, Inc., New York, pp. 124-129, 1988. |
Gibbs, Jackson B. and Oliff, Allen, “Pharmaceutical research in molecular oncology,” Cell, 79:193-198, 1994. |
Guise, Theresa A. and Mundy, Gregory R., “Cancer and bone,” Endocrine Reviews 19(1):18-54,1998. |
Huang, Jing and Schreiber, Stuart L., “A yeast genetic system for selecting small molecule inhibitors of protein-protein interaction in nanodroplets,” Proc. Natl. Acad. Sci. USA, 94:13396-13401, 1997. |
Lacey et al., “Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation,” Cell, 93:165-175, 1998. |
Lynch et al, “A fluorescence polarization based Src-SH2 binding assay,” Analytical Biochemistry, 247:77-82, 1997. |
Pullen et al., “CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization,” Biochemistry, 37 (34):11836-11845, 1998. |
Roodman, G. David, “Advances in bone biology: the osteoclast,” Endocrine Reviews 17(4):308-332, 1996. |
Rossi et al., “Monitoring protein-protein interactions in intact eukaryotic cells by β-galactosidase complementation,” Proc. Natl. Acad. Sci. USA, 91:8405-8410, 1997. |
Rothe, M. et al., “The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins,” Cell, 83:1243-1252, 1995. |
Smith, C. et al., “A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins,” Sci. 248:1019-1022, 1990. |
Suda et al., “Modulation of osteoclast differentiation by local factors,” Bone 17(2):87S-91S; 1995. |
Suda et al., Endocr. Rev. 13:66; 1992. |
Suda et al., “Modulation of osteoclast differentiation: update 1995,” in Endocrine Review Monographs,4(1):266-270; 1995. |
White, Michael A., “The yeast two-hybrid system: forward and reverse,” Proc. Natl. Acad. Sci. USA, 93:10001-10003, 1996. |
Wong et al., “TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells,” J. of Biological Chemistry, 272 (40):25190-25194 1997. |
Wong et al., “The TRAF family of signal transducers mediates NF-κB activation by the TRANCE receptor,” J. Biol. Chem., 273(43):28355-28359, 1998. |
Xing et al., “Mechanisms by which NF-κB regulates osteoclast numbers,” Abstract ASBMR Meeting, U of TX Health Science Center, 1998. |
Xu et al., “Targeted disruption of TRAF3 leads to postnatal lethality and defective T-dependent immune responses,” Immunity, 5:407-415, 1996. |
Yasuda et al., Proc. Natl. Acad. Sci. 95:3597; 1998. |